All Stories

  1. Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection
  2. A monogenic autoinflammatory disease with fatal vasculitis
  3. Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study
  4. Evaluation of co-existing diseases in children with familial Mediterranean fever
  5. Performance of recently proposed periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome criteria in a region endemic for familial Mediterranean fever
  6. Serological screening for celiac disease in children with systemic lupus erythematosus
  7. Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single‐center experience
  8. Superb Microvascular Imaging Compared With Power Doppler Ultrasound in Assessing Synovitis of the Knee in Juvenile Idiopathic Arthritis: A Preliminary Study
  9. Serological screening for coeliac disease in patients with juvenile idiopathic arthritis
  10. Serological Evidence of Tick-Borne Encephalitis and West Nile Virus Infections Among Children with Arthritis in Turkey
  11. Leap Motion Controller–based training for upper extremity rehabilitation in children and adolescents with physical disabilities: A randomized controlled trial
  12. Anaphylactic reaction to anakinra in a child with steroid-dependent idiopathic recurrent pericarditis and successful management with canakinumab
  13. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
  14. Correction to: Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study
  15. Consensus-based recommendations for the management of juvenile localised scleroderma
  16. Spectrum of the neurologic manifestations in childhood-onset cryopyrin-associated periodic syndrome
  17. Effects of Video Games–Based Task-Oriented Activity Training (Xbox 360 Kinect) on Activity Performance and Participation in Patients With Juvenile Idiopathic Arthritis
  18. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study
  19. Fatigue and sleep in children and adolescents with juvenile idiopathic arthritis:a cross-sectional study
  20. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α
  21. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis
  22. Pediatric rheumatology in Turkey
  23. Hepatitis A virus vaccination in childhood-onset systemic lupus erythematosus
  24. Tuberculin skin test response in patients with juvenile idiopathic arthritis on anti-TNF therapy
  25. The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study
  26. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center
  27. Evaluation of six-minute walk test in juvenile systemic sclerosis
  28. Juvenile Scleroderma-What has Changed in the Meantime?
  29. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials
  30. Juvenile Scleroderma: A Referral Center Experience
  31. Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort
  32. Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences
  33. Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus
  34. The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis
  35. SEROLOGICAL SCREENING FOR CELIAC DISEASE IN CHILDREN WITH COLCHICINE-RESISTANT FAMILIAL MEDITERRANEAN FEVER
  36. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
  37. Comparison of Familial Mediterranean Fever and juvenile idiopathic arthritis patients according to family origin
  38. LACC1 Gene Defects in Familial Form of Juvenile Arthritis
  39. The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
  40. The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey
  41. Genotype-phenotype investigation of 35 patients from 11 unrelated families with camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome
  42. Mucolipidosis type III gamma: Three novel mutation and genotype-phenotype study in eleven patients
  43. PFAPA Syndrome in a Population with Endemic Familial Mediterranean Fever
  44. Comparison of Early-Onset and Late-Onset Pediatric Systemic Lupus Erythematosus
  45. Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome
  46. Role of genetics in pediatric rheumatology
  47. The performance of classification criteria for juvenile spondyloarthropathies
  48. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
  49. New Insights into Cardiac Involvement in Juvenile Scleroderma: A Three-Dimensional Echocardiographic Assessment Unveils Subclinical Ventricle Dysfunction
  50. Familial Mediterranean fever in childhood: a single-center experience
  51. Emotional and behavioral influence of headache in Pediatric rheumatic diseases
  52. Evaluation of pulmonary artery pressure in patients with juvenile systemic lupus erythematosus (SLE)
  53. Deficiency of Complement 1r Subcomponent in Early-Onset Systemic Lupus Erythematosus: The Role of Disease-Modifying Alleles in a Monogenic Disease
  54. Erratum to: Evaluation of cardiac functions in juvenile systemic lupus erythematosus with two-dimensional speckle tracking echocardiography
  55. REST Final-Exon-Truncating Mutations Cause Hereditary Gingival Fibromatosis
  56. An Unusual Association of Pyoderma Gangrenosum with Henoch-Schonlein Purpura in a Child
  57. Evaluation of myocardial deformation in patients with Kawasaki disease using speckle-tracking echocardiography during mid-term follow-up – CORRIGENDUM
  58. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency
  59. The impact of peer victimization and psychological symptoms on quality of life in children and adolescents with systemic lupus erythematosus
  60. Evaluation of myocardial deformation in patients with Kawasaki disease using speckle-tracking echocardiography during mid-term follow-up
  61. Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey
  62. Juvenile Idiopathic Arthritis
  63. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus
  64. The frequency of the celiac disease among children with familial Mediterranean fever
  65. Juvenile dermatomyositis: a tertiary center experience
  66. Idiopathic Pulmonary Hemosiderosis in a Child with Recurrent Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis
  67. Successful Hyperbaric Oxygen Treatment of Gangrenous Lesions due to Systemic Lupus Erythematosus
  68. TNF-alpha 863C > A promoter and TNFRII 196T > G exonic variationsmay be risk factors for juvenile idiopathic arthritis
  69. Sjögren’s syndrome associated with systemic lupus erythematosus
  70. Cardiac involvement in juvenile idiopathic arthritis
  71. Juvenile Spondyloarthropathies
  72. Potential of Serum and Urinary Matrix Metalloproteinase-9 Levels for the Early Detection of Renal Involvement in Children With Henoch-Schönlein Purpura
  73. Hyperimmunoglobulinaemia D syndrome: a rare cause of prolonged fever and treatment with anti-interleukin 1 agent
  74. Evaluation of cardiac functions in juvenile systemic lupus erythematosus with two-dimensional speckle tracking echocardiography
  75. Vitamin D levels in children with familial Mediterranean fever
  76. Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever – a randomized controlled noninferiority trial
  77. Screening of Free Carnitine and Acylcarnitine Status in Children With Familial Mediterranean Fever
  78. Relationship between vitamin B12, homocysteine and oxidative stress in juvenile idiopathic arthritis
  79. Panniculitis in juvenile dermatomyositis: Report of a case and review of the published work
  80. Primary catastrophic antiphospholipid syndrome in an 8 year-old girl
  81. Childhood-onset eosinophilic granulomatosis with polyangiitis: a rare childhood vasculitis mimicking anthrax and eosinophilic leukaemia
  82. Pediatric vasculitis
  83. Renovasküler Hipertansiyon İle Gelen Takayasu Arteritli Bir Olgu
  84. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
  85. A Case of Acute Rheumatic Fever With Henoch Schonlein Purpura
  86. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD
  87. Screening Inherited Metabolic Disorders in Patients with Familial Mediterranean Fever
  88. Diagnostic approach and current treatment options in childhood vasculitis
  89. Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period
  90. Cost of Familial Mediterranean Fever (Fmf) Disease In Turkey
  91. How Pricing And Reimbursement Policies Affect The Budget Impact of The Treatment of Systemic Juvenile Idiopathic Arthritis In Turkey
  92. Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
  93. Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
  94. Pathological and immunological features of autoinflammatory syndrome associated with lymphedema (AISLE)
  95. Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF
  96. Turkish Pediatric Rheumatology Society consensus statements on systemic onset juvenile idiopathic arthritis in Turkey
  97. Achromobacter causing a thrombophlebitis and osteomyelitis combination: a rare cause: Figure 1
  98. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
  99. Chronic recurrent multifocal osteomyelitis: a rare skeletal disorder
  100. The frequency of pulmonary hypertension in patients with juvenile scleroderma
  101. A difficult case of Hodgkin Lymphoma with differential diagnosis of tuberculosis and sarcoidosis
  102. Effect of Strengthening Versus Balance-Proprioceptive Exercises on Lower Extremity Function in Patients with Juvenile Idiopathic Arthritis
  103. Biological Agents in Familial Mediterranean Fever Focusing on Colchicine Resistance and Amyloidosis
  104. Treatment in juvenile rheumatoid arthritis and new treatment options
  105. Canakinumab: new treatment choice for systemic juvenile idiopathic arthritis
  106. Abdominal pain developing from a polyarteritis nodosa-induced hepatic aneurysm
  107. Acute granulomatous iridocyclitis in a child with tubulointerstitial nephritis and uveitis syndrome
  108. Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis
  109. Familial Mediterranean Fever in childhood: a single center experience
  110. Articular involvement in childhood Familial Mediterranean Fever
  111. A case of systemic juvenile idiopathic arthritis with pulmonary hemosiderosis secondary to recurrent macrophage activation syndrome or a new autoinflammatory syndrome?
  112. Developing of a new scale for assessing the adherence to colchicine treatment in pediatric patients with FMF
  113. Development of focal segmental glomerulosclerosis in a patient with Familial Mediterranean Fever resistant to colchicine therapy under treatment with Canakinumab
  114. Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever
  115. Screening of free carnitine and acyl-carnitine status in patients with Familial Mediterranean Fever
  116. Primary headaches in pediatric patients with chronic rheumatic disease
  117. Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
  118. Association of familial Mediterranean fever in Turkish children with inflammatory bowel disease
  119. Use of tissue Doppler and its comparison with other pulse Doppler echocardiography in the evaluation of diastolic functions in patients with active juvenile idiopathic arthritis
  120. Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up
  121. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy
  122. Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy
  123. FMF50: a score for assessing outcome in familial Mediterranean fever
  124. CINCA syndrome in an infant presenting with hydrocephalus
  125. The new proposal classification criteria for juvenile spondyloarthropathies
  126. Autoinflammatory diseases in childhood
  127. The frequency of pulmonary hypertension in juvenile scleroderma
  128. Regular Aerobic Training Combined with Range of Motion Exercises in Juvenile Idiopathic Arthritis
  129. Juvenile dermatomyositis: clinical features, laboratory findings, treatment modalities and disease course (a single center experience)
  130. Increased frequency of psoriasis in the families of subjects with childhood Familial Mediterranean Fever
  131. Evaluation of ppd response in patients with idiopathic arthritis who are on biological drug therapy
  132. Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up
  133. Clinical presentations and molecular basis of complement C1R mutation in a large turkish family
  134. Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
  135. SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis
  136. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration
  137. Severe digital necrosis in a 4-year-old boy: primary Raynaud's or jellyfish sting
  138. Sarcoidosis infantil. Un caso clínico infrecuente
  139. An unusual case of childhood sarcoidosis
  140. Tuberculous Meningitis in a Patient with Systemic Lupus Erythematosus
  141. DNASE1L3Mutations in Hypocomplementemic Urticarial Vasculitis Syndrome
  142. Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: Immunogenicity and safety?
  143. Multiple small hyperintense lesions in the subcortical white matter on cranial MR images in two Turkish brothers with cold-induced sweating syndrome caused by a novel missense mutation in the CRLF1 gene
  144. FRI0590-HPR Evaluation of gait in children with juvenile idiopathic arthritis
  145. Association of Inflammatory Bowel Disease With Familial Mediterranean Fever in Turkish Children
  146. Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood
  147. P01-016 – Decreased vitamin D levels in FMF patients
  148. P01-019 – Anti-CCP antibodies are not associated with FMF
  149. PW01-015 – Canakinumab in adults with colchicin resistant FMF
  150. PReS-FINAL-2097: Evaluation of gait in children with juvenile idiopathic arthritis
  151. PReS-FINAL-2042: Health-related quality of-life in Turkish children and adolescents with juvenile idiopathic arthritis
  152. Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
  153. Lupus nefritli bir olguda sistemik steroidlerin ender bir komplikasyonu: mediyastinal lipomatoz olgusu
  154. Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus
  155. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
  156. Cross-cultural adaptation, reliability, and validity of the Turkish version of PedsQL 3.0 Arthritis Module: a quality-of-life measure for patients with juvenile idiopathic arthritis in Turkey
  157. T-CELL LYMPHOMA MASQUERADING AS JUVENILE RHEUMATOID ARTHRITIS
  158. Assesing the Effect of ANA Positivity on Clinical Picture of the Juvenile Idiopathic Arthritis in a Large Cohort of Turkish Ancestry
  159. Pneumococcal Vaccination in Juvenile Idiopathic Arthritis
  160. Efficacy of a land-based home exercise programme for patients with juvenile idiopathic arthritis: A randomized, controlled, single-blind study
  161. QT dispersion and cardiac involvement in children with Familial Mediterranean fever
  162. Clinical characteristics of pediatric-onset neuro-Behcet disease
  163. Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease?
  164. QT dispersion and cardiac involvement in patients with juvenile idiopathic arthritis
  165. The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis
  166. F213 THE RELATIONSHIP BETWEEN QUALITY OF LIFE AND PAIN IN JUVENILE IDIOPATHIC ARTHRITIS
  167. Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever
  168. Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?
  169. Increased expression of exon 2 deleted MEFV transcript in familial Mediterranean fever patients
  170. Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever
  171. Ergenlik çağında bağ dokusu hastalıkları
  172. Application of the new pediatric criteria and Tel Hashomer criteria in heterozygous patients with clinical features of FMF
  173. Dialysate CA125 levels after 5 years on continuous peritoneal dialysis
  174. QT dispersion and cardiac involvement in patients with juvenile idiopathic arthritis
  175. Influence of Reduced Folate Carrier and Aminoimidazole Carboxamide Ribonucleotide Transformylase gene polymorphisms on the efficacy of methotrexate in juvenile idiopathic arthritis
  176. Subclinical cardiovascular abnormalities in patients with juvenile systemic lupus erythematosus
  177. Turkish version of the pediatric quality of life inventory (PedsQL) 3.0 arthritis module: a reliability and validity study
  178. A pilot study for genome wide association study (GWAS) in patients with juvenile idiopathic arthritis (JIA) and their parents
  179. P wave dispersion and cardiac involvement in patients with juvenile idiopathic arthritis
  180. Effect of ANA positivity on clinical picture of the JIA: should ANA positive JIA be classified as a different group?
  181. Pelvic MRI findings of juvenile-onset ankylosing spondylitis
  182. Renovascular hypertension in a child with Marfan syndrome
  183. Classic polyarteritis nodosa presenting with acute anuric renal failure
  184. Eklem ağrısı ile başvuran çocukta ayırıcı tanı
  185. Do infections trigger juvenile idiopathic arthritis?
  186. Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis
  187. Left ventricular function by ‘conventional’ and ‘tissue Doppler’ echocardiography in paediatric dialysis patients
  188. Purified Protein Derivative Response in Juvenile Idiopathic Arthritis
  189. Juvenile linear scleroderma with unique forms of renal involvement
  190. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood
  191. Retrospective analysis of children with uveitis treated with infliximab
  192. Progression of coronary calcification in pediatric chronic kidney disease stage 5
  193. Factors affecting survival in juvenile systemic sclerosis
  194. MEFV Mutations Modify the Clinical Presentation of Henoch-Schönlein Purpura
  195. Left ventricular systolic and diastolic function and carotid intima-media thickness in pediatric dialysis patients
  196. A Case of Catastrophic Antiphospholipid Syndrome in an Adolescent Girl With Parvovirus B19 Infection
  197. Dissection of the abdominal aorta in a child with takayasu's arteritis
  198. Depression, anxiety and pain in juvenile idiopathic arthritis
  199. Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
  200. Prevalence of the MEFV Gene Mutations in Childhood Polyarteritis Nodosa
  201. A Child With Primary Sjögren Syndrome and a Review of the Literature
  202. Is Familial Mediterranean Fever a thrombotic disease or not?
  203. Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients
  204. Coronary artery calcifications in children with end-stage renal disease
  205. Childhood vasculitides in Turkey: a nationwide survey
  206. Systemic lupus erythematosus due to Epstein–Barr virus or Epstein–Barr virus infection provocating acute exacerbation of systemic lupus erythematosus?
  207. Dialysate CA125 levels in children on continuous peritoneal dialysis
  208. Antibody Titers and Immune Response to Diphtheria-Tetanus-Pertussis and Measles-Mumps-Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia
  209. THE ANEMIA OF FAMILIAL MEDITERRANEAN FEVER DISEASE
  210. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core set
  211. Familial Mediterranean Fever (FMF) in Turkey
  212. Albuminuria and tubular markers in juvenile idiopathic arthritis
  213. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis
  214. Juvenile polyarteritis: Results of a multicenter survey of 110 children
  215. Hepatitis B vaccination in children with juvenile idiopathic arthritis
  216. Is there any relationship between Chlamydophila pneumoniae infection and juvenile idiopathic arthritis?
  217. The Role of Streptococcal Infection in Henoch-Schonlein Purpura
  218. Evaluation of classification criteria for juvenile-onset spondyloarthropathies
  219. Toxic hepatitis due to enalapril in childhood
  220. Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients
  221. MRI findings of hypoxic cortical laminar necrosis in a child with hemolytic anemia crisis
  222. The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa
  223. A survey of phenotype II in familial Mediterranean fever
  224. Picture of the Month
  225. Obesity and erythrocyte sedimentation rate in children